212 related articles for article (PubMed ID: 30429678)
21. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.
Verbeek HH; de Groot JWB; Sluiter WJ; Muller Kobold AC; van den Heuvel ER; Plukker JT; Links TP
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD010159. PubMed ID: 32176812
[TBL] [Abstract][Full Text] [Related]
23. Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?
Verga U; Ferrero S; Vicentini L; Brambilla T; Cirello V; Muzza M; Beck-Peccoz P; Fugazzola L
Endocr Relat Cancer; 2007 Jun; 14(2):393-403. PubMed ID: 17639053
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease.
Herrmann BL; Schmid KW; Goerges R; Kemen M; Mann K
Eur J Endocrinol; 2010 Jun; 162(6):1141-5. PubMed ID: 20332126
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
26. Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays.
Faggiano A; Giannetta E; Modica R; Albertelli M; Barba L; Dolce P; Motta C; Deiana MG; Martinelli R; Zamponi V; Sesti F; Patti L; Scavuzzo F; Colao A; Monti S
Minerva Endocrinol (Torino); 2023 Sep; 48(3):253-260. PubMed ID: 37326573
[TBL] [Abstract][Full Text] [Related]
27. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
28. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
[TBL] [Abstract][Full Text] [Related]
30. Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.
Bae YJ; Schaab M; Kratzsch J
Recent Results Cancer Res; 2015; 204():117-37. PubMed ID: 26494386
[TBL] [Abstract][Full Text] [Related]
31. ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus.
Giannetta E; Guarnotta V; Altieri B; Sciammarella C; Guadagno E; Malandrino P; Puliani G; Feola T; Isidori AM; Colao AAL; Faggiano A
Eur J Endocrinol; 2020 Dec; 183(6):R197-R215. PubMed ID: 33112280
[TBL] [Abstract][Full Text] [Related]
32. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
33. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
[TBL] [Abstract][Full Text] [Related]
34. Calcitonin levels by ECLIA correlate well with RIA values in higher range but are affected by sex, TgAb, and renal function in lower range.
Ito Y; Kaneko H; Sasaki Y; Ohana N; Ichijo M; Furuya F; Suzuki S; Suzuki S; Shimura H
Endocr J; 2020 Jul; 67(7):759-770. PubMed ID: 32269183
[TBL] [Abstract][Full Text] [Related]
35. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
36. Negative predictive value of procalcitonin in medullary thyroid carcinoma.
Lim SK; Guéchot J; Vaubourdolle M
Ann Biol Clin (Paris); 2016; 74(2):213-8. PubMed ID: 26806393
[TBL] [Abstract][Full Text] [Related]
37. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
Rosario PW; Calsolari MR
Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
[TBL] [Abstract][Full Text] [Related]
39. Comparison of serum calcitonin and procalcitonin in detecting medullary thyroid carcinoma among patients with thyroid nodules.
Giovanella L; Verburg FA; Imperiali M; Valabrega S; Trimboli P; Ceriani L
Clin Chem Lab Med; 2013 Jul; 51(7):1477-81. PubMed ID: 23314540
[TBL] [Abstract][Full Text] [Related]
40. Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.
Machens A; Hoffmann F; Sekulla C; Dralle H
Endocr Relat Cancer; 2009 Dec; 16(4):1291-8. PubMed ID: 19726541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
